Accessibility Menu
 
Cognetivity Neurosciences logo

Cognetivity Neurosciences

(OTC) CGNSF

Current Price$0.00
Market CapN/A
Since IPO (2018)-100%
5 Year-100%
1 Year-100%
1 Month+0%

Cognetivity Neurosciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$98.97K

Net Income (TTM)

$8.64M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-4.77 (Low)

Price

$0.00

Volume

700

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

CGNSF News

No articles available.

CGNSF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cognetivity Neurosciences

Industry

Healthcare Equipment and Supplies

CEO

Sina Habibi, PhD

Headquarters

Vancouver, BC V6E 2E9, CA

CGNSF Financials

Key Financial Metrics (TTM)

Gross Margin

46%

Operating Margin

-141%

Net Income Margin

-164%

Return on Equity

0%

Return on Capital

82%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

700

Short Interest

0.00%

Avg. Volume

519.672

Financials (TTM)

Gross Profit

$2.13M

Operating Income

$6.29M

EBITDA

$6.38M

Operating Cash Flow

$5.94M

Capital Expenditure

$69.69K

Free Cash Flow

$6.01M

Cash & ST Invst.

$2.24M

Total Debt

$1.29M

Cognetivity Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$29.16K

N/A

Gross Profit

$451.14K

-6821.4%

Gross Margin

-15.47%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

2,500

N/A

Net Income

$2.04M

-13.4%

EBITDA

$700.29K

+59.2%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$1.35M

-149.5%

Accounts Receivable

$251.78K

N/A

Inventory

$0.00

+100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.37M

+794.9%

Return on Assets

-2.63%

N/A

Return on Invested Capital

82.30%

N/A

Free Cash Flow

$1.69K

+99.3%

Operating Cash Flow

$16.93K

+107.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EMEDElectromedical Technologies, Inc.
$0.00+100.00%
EMYSFEasy Technologies Inc.
$0.01+0.00%
HPMMHemp Naturals, Inc.
$0.00+0.00%
SHWZMedicine Man Technologies, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%

Questions About CGNSF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.